A new model for the population pharmacokinetics of didanosine in healthy subjects
Didanosine (ddI) is a component of highly active antiretroviral therapy drug combinations, used especially in resource-limited settings and in zidovudine-resistant patients. The population pharmacokinetics of ddI was evaluated in 48 healthy volunteers enrolled in two bioequivalence studies. These da...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Associação Brasileira de Divulgação Científica
2007-01-01
|
| Серія: | Brazilian Journal of Medical and Biological Research |
| Предмети: | |
| Онлайн доступ: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2007000100013 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|